AM
AnGes, Inc.
AMGXF · OTC
$0.36 +0.00% (+$0.00)
Market Cap ¥22.4B
P/E Ratio -
Div. Yield -
ROE 162.36%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 109.83x
P/S 23.25x
PEG N/A
Growth
78 /100
Growing Book val. growth 53.40%
Rev. growth 135.41%
FCF growth N/A
Profitability
18 /100
Weak FCF margin 0.00%
Op. margin 621.56%
Gross margin 41.35%
Quality
3 /100
Poor Asset turnover 0.27x
ROA 106.71%
ROIC 581.32%
Debt
8 /100
High Current ratio 0.95x
Int. coverage -388.66x
Debt/Equity 3.52x
Stability
26 /100
Unstable Profitable years 0
EPS volatility 171.29%
Beta 0.61x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AMGXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ei Yamada
Employees
56
Headquarters
Ibaraki
Nadcházející události
06 LIS
Earnings
Upcoming earnings report